Inventor · disambiguated record
Orson W. Moe
Also filed as: MOE ORSON W
8 granted patents·2 pending applications·1 citations·filing 2013–2020
73Inventor score
Top patents by PatentIndex Score
10 records- 0167US9539283B2Citrate-rich calcium-magnesium supplement and uses thereofUNIV TEXAS·Filed 2013·Granted Jan 10, 2017·1 cites·8 claims
- 0259US10697963B2Nucleic acids encoding antibodies with high affinity for Alpha-KlothoGOVERNING COUNCIL UNIV TORONTO·Filed 2019·Granted Jun 30, 2020·0 cites·14 claims
- 0355US11143661B2Antibodies that specifically bind alpha klothoGOVERNING COUNCIL UNIV TORONTO·Filed 2020·Granted Oct 12, 2021·0 cites·14 claims
- 0452US10912791B2Compositions comprising antisense-encoded erythropoietin receptor and use thereofUNIV TEXAS·Filed 2017·Granted Feb 9, 2021·0 cites·21 claims
- 0548US10092593B2Citrate-rich calcium-magnesium supplement and uses thereofUNIV TEXAS·Filed 2016·Granted Oct 9, 2018·0 cites·11 claims
- 0646US10663474B2Antibodies which specifically bind αKlotho polypeptideGOVERNING COUNCIL UNIV TORONTO·Filed 2017·Granted May 26, 2020·0 cites·12 claims
- 0746US10228374B2Antibodies with high affinity for alpha-KlothoGOVERNING COUNCIL UNIV TORONTO·Filed 2015·Granted Mar 12, 2019·0 cites·8 claims
- 0843US11491115B2Nanoparticles containing extracellular matrix for drug deliveryUNIV TEXAS·Filed 2016·Granted Nov 8, 2022·0 cites·12 claims
- 0943US2020078395A1Averting complications of pump inhibitor therapy by effervescent calcium magnesium citrateUNIV TEXAS·Filed 2019·Application pending·0 cites
- 1038US2017281578A1Methods for treating metabolic disturbancesUNIV TEXAS·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →